Reviews - 1dx5 mentioned but not cited (7)
- Exosites in the substrate specificity of blood coagulation reactions. Bock PE, Panizzi P, Verhamme IM. J. Thromb. Haemost. 5 Suppl 1 81-94 (2007)
- Machine Learning Approaches for Protein⁻Protein Interaction Hot Spot Prediction: Progress and Comparative Assessment. Liu S, Liu C, Deng L. Molecules 23 E2535 (2018)
- High-Molecular-Weight Glutenin Subunits: Genetics, Structures, and Relation to End Use Qualities. Li Y, Fu J, Shen Q, Yang D. Int J Mol Sci 22 E184 (2020)
- Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. Sillen M, Declerck PJ. Int J Mol Sci 22 3670 (2021)
- Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands. Troisi R, Balasco N, Autiero I, Vitagliano L, Sica F. Int J Mol Sci 22 10803 (2021)
- Gliadin and glutenin genomes and their effects on the technological aspect of wheat-based products. Pourmohammadi K, Abedi E, Hashemi SMB. Curr Res Food Sci 7 100622 (2023)
- Sulfotyrosine residues: Interaction specificity determinants for extracellular protein-protein interactions. Stewart V, Ronald PC. J Biol Chem 298 102232 (2022)
Articles - 1dx5 mentioned but not cited (39)
- Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Gasper PM, Fuglestad B, Komives EA, Markwick PR, McCammon JA. Proc. Natl. Acad. Sci. U.S.A. 109 21216-21222 (2012)
- Crystal structure of an RNA aptamer bound to thrombin. Long SB, Long MB, White RR, Sullenger BA. RNA 14 2504-2512 (2008)
- Interaction preferences across protein-protein interfaces of obligatory and non-obligatory components are different. De S, Krishnadev O, Srinivasan N, Rekha N. BMC Struct Biol 5 15 (2005)
- Generation of novel high quality HMW-GS genes in two introgression lines of Triticum aestivum/Agropyron elongatum. Liu S, Zhao S, Chen F, Xia G. BMC Evol Biol 7 76 (2007)
- Molecular structures and interactions of repetitive peptides based on wheat glutenin subunits depend on chain length. Feeney KA, Wellner N, Gilbert SM, Halford NG, Tatham AS, Shewry PR, Belton PS. Biopolymers 72 123-131 (2003)
- Characterizing HMW-GS alleles of decaploid Agropyron elongatum in relation to evolution and wheat breeding. Liu S, Gao X, Xia G. Theor. Appl. Genet. 116 325-334 (2008)
- Designing coarse grained-and atom based-potentials for protein-protein docking. Tobi D. BMC Struct. Biol. 10 40 (2010)
- Two quality-associated HMW glutenin subunits in a somatic hybrid line between Triticum aestivum and Agropyron elongatum. Feng D, Xia G, Zhao S, Chen F. Theor. Appl. Genet. 110 136-144 (2004)
- Characterization and comparative analysis of HMW glutenin 1Ay alleles with differential expressions. Jiang QT, Wei YM, Wang F, Wang JR, Yan ZH, Zheng YL. BMC Plant Biol. 9 16 (2009)
- Molecular basis of thrombomodulin activation of slow thrombin. Adams TE, Li W, Huntington JA. J. Thromb. Haemost. 7 1688-1695 (2009)
- Novel x-type high-molecular-weight glutenin genes from Aegilops tauschii and their implications on the wheat origin and evolution mechanism of Glu-D1-1 proteins. Zhang Y, Li X, Wang A, An X, Zhang Q, Pei Y, Gao L, Ma W, Appels R, Yan Y. Genetics 178 23-33 (2008)
- Enrichment of provitamin A content in wheat (Triticum aestivum L.) by introduction of the bacterial carotenoid biosynthetic genes CrtB and CrtI. Wang C, Zeng J, Li Y, Hu W, Chen L, Miao Y, Deng P, Yuan C, Ma C, Chen X, Zang M, Wang Q, Li K, Chang J, Wang Y, Yang G, He G. J. Exp. Bot. 65 2545-2556 (2014)
- Novel variants of HMW glutenin subunits from Aegilops section Sitopsis species in relation to evolution and wheat breeding. Jiang QT, Ma J, Wei YM, Liu YX, Lan XJ, Dai SF, Lu ZX, Zhao S, Zhao QZ, Zheng YL. BMC Plant Biol 12 73 (2012)
- Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Treuheit NA, Beach MA, Komives EA. Biochemistry 50 4590-4596 (2011)
- Chromosome Specific Substitution Lines of Aegilops geniculata Alter Parameters of Bread Making Quality of Wheat. Garg M, Tsujimoto H, Gupta RK, Kumar A, Kaur N, Kumar R, Chunduri V, Sharma NK, Chawla M, Sharma S, Mundey JK. PLoS ONE 11 e0162350 (2016)
- Haplotype variation of Glu-D1 locus and the origin of Glu-D1d allele conferring superior end-use qualities in common wheat. Dong Z, Yang Y, Li Y, Zhang K, Lou H, An X, Dong L, Gu YQ, Anderson OD, Liu X, Qin H, Wang D. PLoS ONE 8 e74859 (2013)
- The wheat HMW-glutenin 1Dy10 gene promoter controls endosperm expression in Brachypodium distachyon. Thilmony R, Guttman ME, Lin JW, Blechl AE. GM Crops Food 5 36-43 (2014)
- Dissecting the Disulfide Linkage of the N-Terminal Domain of HMW 1Dx5 and Its Contributions to Dough Functionality. Wang JJ, Liu G, Huang YB, Zeng QH, Hou Y, Li L, Ou S, Zhang M, Hu SQ. J Agric Food Chem 65 6264-6273 (2017)
- Identification and characterization of high-molecular-weight glutenin subunits from Agropyron intermedium. Cao S, Li Z, Gong C, Xu H, Yang R, Hao S, Wang X, Wang D, Zhang X. PLoS One 9 e87477 (2014)
- Role of N-terminal domain of HMW 1Dx5 in the functional and structural properties of wheat dough. Wang JJ, Liu G, Huang YB, Zeng QH, Song GS, Hou Y, Li L, Hu SQ. Food Chem 213 682-690 (2016)
- Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin. Handley LD, Treuheit NA, Venkatesh VJ, Komives EA. Biochemistry 54 6650-6658 (2015)
- Volume-based solvation models out-perform area-based models in combined studies of wild-type and mutated protein-protein interfaces. Bougouffa S, Warwicker J. BMC Bioinformatics 9 448 (2008)
- Effect of extra cysteine residue of new mutant 1Ax1 subunit on the functional properties of common wheat. Li M, Wang Y, Ma F, Zeng J, Chang J, Chen M, Li K, Yang G, Wang Y, He G. Sci Rep 7 7510 (2017)
- Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Beaudoin CA, Jamasb AR, Alsulami AF, Copoiu L, van Tonder AJ, Hala S, Bannerman BP, Thomas SE, Vedithi SC, Torres PHM, Blundell TL. Comput Struct Biotechnol J 19 3938-3953 (2021)
- Prediction of hot spots in protein interfaces using extreme learning machines with the information of spatial neighbour residues. Wang L, Zhang W, Gao Q, Xiong C. IET Syst Biol 8 184-190 (2014)
- The wPDI Redox Cycle Coupled Conformational Change of the Repetitive Domain of the HMW-GS 1Dx5-A Computational Study. Gao J, Yu P, Liang H, Fu J, Luo Z, Yang D. Molecules 25 E4393 (2020)
- The soluble recombinant N-terminal domain of HMW 1Dx5 and its aggregation behavior. Wang JJ, Liu GY, Liu G, Zeng QH, Shen X, Hou Y, Li L, Hu SQ. Food Res Int 78 201-208 (2015)
- Study of wheat high molecular weight 1Dx5 subunit by (13)C and (1)H solid-state NMR. II. Roles of nonrepetitive terminal domains and length of repetitive domain. Alberti E, Gilbert SM, Tatham AS, Shewry PR, Naito A, Okuda K, Saitô H, Gil AM. Biopolymers 65 158-168 (2002)
- Whole-exome sequencing in evaluation of patients with venous thromboembolism. Lee EJ, Dykas DJ, Leavitt AD, Camire RM, Ebberink E, García de Frutos P, Gnanasambandan K, Gu SX, Huntington JA, Lentz SR, Mertens K, Parish CR, Rezaie AR, Sayeski PP, Cromwell C, Bar N, Halene S, Neparidze N, Parker TL, Burns AJ, Dumont A, Yao X, Chaar CIO, Connors JM, Bale AE, Lee AI. Blood Adv 1 1224-1237 (2017)
- Gluten Conformation at Different Temperatures and Additive Treatments. Chompoorat P, Fasasi A, Lavine BK, Rayas-Duarte P. Foods 11 430 (2022)
- Proteogenomic Characterization of Novel x-Type High Molecular Weight Glutenin Subunit 1Ax1.1. Ribeiro M, Bancel E, Faye A, Dardevet M, Ravel C, Branlard G, Igrejas G. Int J Mol Sci 14 5650-5667 (2013)
- Two Novel Y-Type High Molecular Weight Glutenin Genes in Chinese Wheat Landraces of the Yangtze-River Region. Peng Y, Yu K, Zhang Y, Islam S, Sun D, Ma W. PLoS ONE 10 e0142348 (2015)
- A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation. Okada M, Tominaga N, Honda G, Nishioka J, Akita N, Hayashi T, Suzuki K, Moriuchi H. Blood Adv 4 2631-2639 (2020)
- Cellular Localization of Wheat High Molecular Weight Glutenin Subunits in Transgenic Rice Grain. Jo YM, Cho K, Lee HJ, Lim SH, Kim JS, Kim YM, Lee JY. Int J Mol Sci 18 (2017)
- Deletion of high-molecular-weight glutenin subunits in wheat significantly reduced dough strength and bread-baking quality. Zhang Y, Hu M, Liu Q, Sun L, Chen X, Lv L, Liu Y, Jia X, Li H. BMC Plant Biol. 18 319 (2018)
- How Thrombomodulin Enables W215A/E217A Thrombin to Cleave Protein C but Not Fibrinogen. Peacock RB, McGrann T, Zaragoza S, Komives EA. Biochemistry 61 77-84 (2022)
- Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation. Fang Y, Zhang Y, Jia C, Ren C, Zhao X, Zhang X. Front Pharmacol 14 1047184 (2023)
- Rational Design of Protein C Activators. Barranco-Medina S, Murphy M, Pelc L, Chen Z, Di Cera E, Pozzi N. Sci Rep 7 44596 (2017)
- Serine protease dynamics revealed by NMR analysis of the thrombin-thrombomodulin complex. Peacock RB, McGrann T, Tonelli M, Komives EA. Sci Rep 11 9354 (2021)
Reviews citing this publication (55)
- HTRA proteases: regulated proteolysis in protein quality control. Clausen T, Kaiser M, Huber R, Ehrmann M. Nat. Rev. Mol. Cell Biol. 12 152-162 (2011)
- Thrombomodulin. Weiler H, Isermann BH. J. Thromb. Haemost. 1 1515-1524 (2003)
- Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Dahlbäck B, Villoutreix BO. Arterioscler. Thromb. Vasc. Biol. 25 1311-1320 (2005)
- Thrombin. Di Cera E. Mol. Aspects Med. 29 203-254 (2008)
- Thrombomodulin and its role in inflammation. Conway EM. Semin Immunopathol 34 107-125 (2012)
- Molecular recognition mechanisms of thrombin. Huntington JA. J. Thromb. Haemost. 3 1861-1872 (2005)
- Serpins in thrombosis, hemostasis and fibrinolysis. Rau JC, Beaulieu LM, Huntington JA, Church FC. J. Thromb. Haemost. 5 Suppl 1 102-115 (2007)
- Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Bajzar L. Arterioscler. Thromb. Vasc. Biol. 20 2511-2518 (2000)
- Exosite-driven substrate specificity and function in coagulation. Krishnaswamy S. J. Thromb. Haemost. 3 54-67 (2005)
- Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Bouma BN, Marx PF, Mosnier LO, Meijers JC. Thromb. Res. 101 329-354 (2001)
- Insights into enzyme structure and dynamics elucidated by amide H/D exchange mass spectrometry. Busenlehner LS, Armstrong RN. Arch. Biochem. Biophys. 433 34-46 (2005)
- Regulation of the protein C anticoagulant and antiinflammatory pathways. Rezaie AR. Curr. Med. Chem. 17 2059-2069 (2010)
- Thrombin interactions. Di Cera E. Chest 124 11S-7S (2003)
- Allosteric disulfide bonds in thrombosis and thrombolysis. Chen VM, Hogg PJ. J. Thromb. Haemost. 4 2533-2541 (2006)
- The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. Esmon CT. J. Autoimmun. 15 113-116 (2000)
- Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C. Faust SN, Heyderman RS, Levin M. Crit. Care Med. 29 S62-7; discussion S67-8 (2001)
- Progress in the understanding of the protein C anticoagulant pathway. Dahlbäck B. Int. J. Hematol. 79 109-116 (2004)
- Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Adams TE, Huntington JA. Arterioscler. Thromb. Vasc. Biol. 26 1738-1745 (2006)
- Structure and interaction modes of thrombin. Bode W. Blood Cells Mol. Dis. 36 122-130 (2006)
- Molecular recognition in the protein C anticoagulant pathway. Dahlbäck B, Villoutreix BO. J. Thromb. Haemost. 1 1525-1534 (2003)
- The link between vascular features and thrombosis. Esmon CT, Esmon NL. Annu. Rev. Physiol. 73 503-514 (2011)
- Determinants of specificity in coagulation proteases. Page MJ, Macgillivray RT, Di Cera E. J. Thromb. Haemost. 3 2401-2408 (2005)
- Targeting thrombin--rational drug design from natural mechanisms. Huntington JA, Baglin TP. Trends Pharmacol. Sci. 24 589-595 (2003)
- Thrombin domains: structure, function and interaction with platelet receptors. De Cristofaro R, De Candia E. J. Thromb. Thrombolysis 15 151-163 (2003)
- Thrombin as procoagulant and anticoagulant. Di Cera E. J. Thromb. Haemost. 5 Suppl 1 196-202 (2007)
- Acquired antithrombin deficiency in sepsis. White B, Perry D. Br. J. Haematol. 112 26-31 (2001)
- Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Suleiman L, Négrier C, Boukerche H. Crit. Rev. Oncol. Hematol. 88 637-654 (2013)
- Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states. Nicolaes GA, Dahlbäck B. Hematol. Oncol. Clin. North Am. 17 37-61, vi (2003)
- The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness. Esmon CT. Crit Care 5 S7-12 (2001)
- Thrombin inhibition by the serpins. Huntington JA. J. Thromb. Haemost. 11 Suppl 1 254-264 (2013)
- Surface loops of trypsin-like serine proteases as determinants of function. Goettig P, Brandstetter H, Magdolen V. Biochimie 166 52-76 (2019)
- Thrombin allostery. Di Cera E, Page MJ, Bah A, Bush-Pelc LA, Garvey LC. Phys Chem Chem Phys 9 1291-1306 (2007)
- Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis. Anastasiou G, Gialeraki A, Merkouri E, Politou M, Travlou A. Blood Coagul. Fibrinolysis 23 1-10 (2012)
- The structure-function relationship of activated protein C. Lessons from natural and engineered mutations. Wildhagen KC, Lutgens E, Loubele ST, ten Cate H, Nicolaes GA. Thromb. Haemost. 106 1034-1045 (2011)
- Thrombin and vascular development: a sticky subject. Moser M, Patterson C. Arterioscler. Thromb. Vasc. Biol. 23 922-930 (2003)
- Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases. Ito T, Kakihana Y, Maruyama I. Expert Opin. Ther. Targets 20 151-158 (2016)
- Natural inhibitors of thrombin. Huntington JA. Thromb. Haemost. 111 583-589 (2014)
- The structure of thrombin, a chameleon-like proteinase. Bode W. J. Thromb. Haemost. 3 2379-2388 (2005)
- Looking at the proteases from a simple perspective. Castro HC, Abreu PA, Abreu PA, Geraldo RB, Martins RC, dos Santos R, Loureiro NI, Cabral LM, Rodrigues CR. J. Mol. Recognit. 24 165-181 (2011)
- Structure-function relationships in thrombin-activatable fibrinolysis inhibitor. Plug T, Meijers JC. J. Thromb. Haemost. 14 633-644 (2016)
- Modes and consequences of thrombin's interaction with fibrin. Fredenburgh JC, Stafford AR, Pospisil CH, Weitz JI. Biophys. Chem. 112 277-284 (2004)
- Structural basis of thrombin-protease-activated receptor interactions. Gandhi PS, Chen Z, Appelbaum E, Zapata F, Di Cera E. IUBMB Life 63 375-382 (2011)
- Clinical impact of novel anticoagulation strategies in sepsis. Opal SM. Curr Opin Crit Care 7 347-353 (2001)
- Thrombomodulin as a Physiological Modulator of Intravascular Injury. Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Front Immunol 11 575890 (2020)
- Exploring traditional and nontraditional roles for thrombomodulin. Loghmani H, Conway EM. Blood 132 148-158 (2018)
- A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics. Mutua V, Gershwin LJ. Clin Rev Allergy Immunol (2020)
- Antiphospholipid antibodies and the coagulation cascade. Anglés-Cano E, Guillin MC. Rheum. Dis. Clin. North Am. 27 573-586 (2001)
- C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation. Khan KA, McMurray JL, Mohammed F, Bicknell R. FEBS J. 286 3299-3332 (2019)
- Dynamic allostery in thrombin-a review. Komives EA. Front Mol Biosci 10 1200465 (2023)
- Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease. Obaha A, Novinec M. Int J Mol Sci 24 17120 (2023)
- Should aspirin be replaced with ADP blockers and anti-GPVI to manage thrombosis? Khan H, Ghulam T, Ahmed N, Rafai Babar M, Calaminus SD, Zuhair Yusuf M. Vasc Biol 5 e220010 (2023)
- Signaling pathways and intervention therapies in sepsis. Zhang YY, Ning BT. Signal Transduct Target Ther 6 407 (2021)
- The Cardioprotective Signaling Activity of Activated Protein C in Heart Failure and Ischemic Heart Diseases. Ren D, Giri H, Li J, Rezaie AR. Int J Mol Sci 20 (2019)
- The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient. Fecher A, Stimpson A, Ferrigno L, Pohlman TH. J Clin Med 10 4793 (2021)
- Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential. Ito T, Thachil J, Asakura H, Levy JH, Iba T. Crit Care 23 280 (2019)
Articles citing this publication (114)
- Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. J. Cell Biol. 169 681-691 (2005)
- Prediction of interface residues in protein-protein complexes by a consensus neural network method: test against NMR data. Chen H, Zhou HX. Proteins 61 21-35 (2005)
- Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Mosnier LO, Griffin JH. Biochem. J. 373 65-70 (2003)
- Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Bae JS, Yang L, Rezaie AR. Proc. Natl. Acad. Sci. U.S.A. 104 2867-2872 (2007)
- Molecular dissection of Na+ binding to thrombin. Pineda AO, Carrell CJ, Bush LA, Prasad S, Caccia S, Chen ZW, Mathews FS, Di Cera E. J. Biol. Chem. 279 31842-31853 (2004)
- The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL. Blood 112 1794-1803 (2008)
- Solvent accessibility of the thrombin-thrombomodulin interface. Mandell JG, Baerga-Ortiz A, Akashi S, Takio K, Komives EA. J. Mol. Biol. 306 575-589 (2001)
- NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation. Lechtenberg BC, Johnson DJ, Freund SM, Huntington JA. Proc. Natl. Acad. Sci. U.S.A. 107 14087-14092 (2010)
- Structural identification of the pathway of long-range communication in an allosteric enzyme. Gandhi PS, Chen Z, Mathews FS, Di Cera E. Proc. Natl. Acad. Sci. U.S.A. 105 1832-1837 (2008)
- Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick. Macedo-Ribeiro S, Almeida C, Calisto BM, Friedrich T, Mentele R, Stürzebecher J, Fuentes-Prior P, Pereira PJ. PLoS ONE 3 e1624 (2008)
- The molecular basis of thrombin allostery revealed by a 1.8 A structure of the "slow" form. Huntington JA, Esmon CT. Structure 11 469-479 (2003)
- The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. Cheng KY, Noble ME, Skamnaki V, Brown NR, Lowe ED, Kontogiannis L, Shen K, Cole PA, Siligardi G, Johnson LN. J Biol Chem 281 23167-23179 (2006)
- Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d'Apice AJ, Cowan PJ. Am. J. Transplant. 8 1101-1112 (2008)
- Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Bah A, Chen Z, Bush-Pelc LA, Mathews FS, Di Cera E. Proc. Natl. Acad. Sci. U.S.A. 104 11603-11608 (2007)
- Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Sperling C, Salchert K, Streller U, Werner C. Biomaterials 25 5101-5113 (2004)
- Crystal structure of wild-type human thrombin in the Na+-free state. Johnson DJ, Adams TE, Li W, Huntington JA. Biochem. J. 392 21-28 (2005)
- Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. Carter WJ, Myles T, Gibbs CS, Leung LL, Huntington JA. J. Biol. Chem. 279 26387-26394 (2004)
- Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. Richardson JL, Kröger B, Hoeffken W, Sadler JE, Pereira P, Huber R, Bode W, Fuentes-Prior P. EMBO J. 19 5650-5660 (2000)
- Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. Panizzi P, Friedrich R, Fuentes-Prior P, Richter K, Bock PE, Bode W. J. Biol. Chem. 281 1179-1187 (2006)
- Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Li W, Adams TE, Nangalia J, Esmon CT, Huntington JA. Proc. Natl. Acad. Sci. U.S.A. 105 4661-4666 (2008)
- Crystal structures and amidolytic activities of two glycosylated snake venom serine proteinases. Zhu Z, Liang Z, Zhang T, Zhu Z, Xu W, Teng M, Niu L. J. Biol. Chem. 280 10524-10529 (2005)
- Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Franchi F, Biguzzi E, Cetin I, Facchetti F, Radaelli T, Bozzo M, Pardi G, Faioni EM. Br. J. Haematol. 114 641-646 (2001)
- Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. Gandhi PS, Chen Z, Di Cera E. J. Biol. Chem. 285 15393-15398 (2010)
- Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Rezaie AR, Yang L. Proc. Natl. Acad. Sci. U.S.A. 100 12051-12056 (2003)
- The contribution of amino acid region ASP695-TYR698 of factor V to procofactor activation and factor Va function. Beck DO, Bukys MA, Singh LS, Szabo KA, Kalafatis M. J. Biol. Chem. 279 3084-3095 (2004)
- The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model. Klement P, Carlsson S, Rak J, Liao P, Vlasin M, Stafford A, Johnston M, Weitz JI. J. Thromb. Haemost. 1 587-594 (2003)
- The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. Myles T, Le Bonniec BF, Stone SR. Eur. J. Biochem. 268 70-77 (2001)
- Placental thrombomodulin expression in recurrent miscarriage. Stortoni P, Cecati M, Giannubilo SR, Sartini D, Turi A, Emanuelli M, Tranquilli AL. Reprod. Biol. Endocrinol. 8 1 (2010)
- Prediction of hot spots in protein interfaces using a random forest model with hybrid features. Wang L, Liu ZP, Zhang XS, Chen L. Protein Eng. Des. Sel. 25 119-126 (2012)
- Effector sites in the three-dimensional structure of mammalian sperm beta-acrosin. Tranter R, Read JA, Jones R, Brady RL. Structure 8 1179-1188 (2000)
- Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease. Rachakonda SP, Penack O, Dietrich S, Blau O, Blau IW, Radujkovic A, Isermann B, Ho AD, Uharek L, Dreger P, Kumar R, Luft T. J. Clin. Oncol. 32 3421-3427 (2014)
- A novel class of small functional peptides that bind and inhibit human alpha-thrombin isolated by mRNA display. Raffler NA, Schneider-Mergener J, Famulok M. Chem. Biol. 10 69-79 (2003)
- Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Bouton MC, Venisse L, Richard B, Pouzet C, Arocas V, Jandrot-Perrus M. Circ. Res. 100 1174-1181 (2007)
- Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation. Wei HJ, Li YH, Shi GY, Liu SL, Chang PC, Kuo CH, Wu HL. Cardiovasc. Res. 92 317-327 (2011)
- Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Yang L, Manithody C, Rezaie AR. Proc. Natl. Acad. Sci. U.S.A. 103 879-884 (2006)
- Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4. Kaplan ZS, Zarpellon A, Alwis I, Yuan Y, McFadyen J, Ghasemzadeh M, Schoenwaelder SM, Ruggeri ZM, Jackson SP. Nat Commun 6 7835 (2015)
- Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro. Mattsson C, Menschik-Lundin A, Nylander S, Gyzander E, Deinum J. Thromb. Res. 104 475-486 (2001)
- Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects. Tsuruta K, Yamada Y, Serada M, Tanigawara Y. J Clin Pharmacol 51 1276-1285 (2011)
- Modeling zymogen protein C. Perera L, Foley C, Darden TA, Stafford D, Mather T, Esmon CT, Pedersen LG. Biophys. J. 79 2925-2943 (2000)
- The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. Yang L, Prasad S, Di Cera E, Rezaie AR. J. Biol. Chem. 279 38519-38524 (2004)
- Ligand binding to anion-binding exosites regulates conformational properties of thrombin. Malovichko MV, Sabo TM, Maurer MC. J. Biol. Chem. 288 8667-8678 (2013)
- Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Figueiredo AC, de Sanctis D, Gutiérrez-Gallego R, Cereija TB, Macedo-Ribeiro S, Fuentes-Prior P, Pereira PJ. Proc. Natl. Acad. Sci. U.S.A. 109 E3649-58 (2012)
- The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex. Wu C, Kim PY, Manuel R, Seto M, Whitlow M, Nagashima M, Morser J, Gils A, Declerck P, Nesheim ME. J. Biol. Chem. 284 7059-7067 (2009)
- Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. Yang L, Manithody C, Walston TD, Cooper ST, Rezaie AR. J. Biol. Chem. 278 37465-37470 (2003)
- Allosteric modulation of monomeric proteins*. Ascenzi P, Bocedi A, Bolli A, Fasano M, Notari S, Polticelli F. Biochem Mol Biol Educ 33 169-176 (2005)
- The affinity of protein C for the thrombin.thrombomodulin complex is determined in a primary way by active site-dependent interactions. Lu G, Chhum S, Krishnaswamy S. J. Biol. Chem. 280 15471-15478 (2005)
- Exposure of R169 controls protein C activation and autoactivation. Pozzi N, Barranco-Medina S, Chen Z, Di Cera E. Blood 120 664-670 (2012)
- Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles. Baerga-Ortiz A, Bergqvist S, Mandell JG, Komives EA. Protein Sci. 13 166-176 (2004)
- GpIbα interacts exclusively with exosite II of thrombin. Lechtenberg BC, Freund SM, Huntington JA. J. Mol. Biol. 426 881-893 (2014)
- Immobilization of actively thromboresistant assemblies on sterile blood-contacting surfaces. Qu Z, Krishnamurthy V, Haller CA, Dorr BM, Marzec UM, Hurst S, Hinds MT, Hanson SR, Liu DR, Chaikof EL. Adv Healthc Mater 3 30-35 (2014)
- Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold. Vogt AD, Chakraborty P, Di Cera E. J. Biol. Chem. 290 22435-22445 (2015)
- The RNA aptamer-binding site of hepatitis C virus NS3 protease. Hwang J, Fauzi H, Fukuda K, Sekiya S, Kakiuchi N, Shimotohno K, Taira K, Kusakabe I, Nishikawa S. Biochem. Biophys. Res. Commun. 279 557-562 (2000)
- Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics? Stites WE, Froude JW. Med. Hypotheses 68 811-821 (2007)
- End-point immobilization of recombinant thrombomodulin via sortase-mediated ligation. Jiang R, Weingart J, Zhang H, Ma Y, Sun XL. Bioconjug. Chem. 23 643-649 (2012)
- The effects of exosite occupancy on the substrate specificity of thrombin. Ng NM, Quinsey NS, Matthews AY, Kaiserman D, Wijeyewickrema LC, Bird PI, Thompson PE, Pike RN. Arch. Biochem. Biophys. 489 48-54 (2009)
- Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. Yang L, Manithody C, Rezaie AR. J. Thromb. Haemost. 7 1696-1702 (2009)
- Identification and computationally-based structural interpretation of naturally occurring variants of human protein C. Rovida E, Merati G, Merati G, D'Ursi P, Zanardelli S, Marino F, Fontana G, Castaman G, Faioni EM. Hum. Mutat. 28 345-355 (2007)
- The elusive role of the potential factor X cation-binding exosite-1 in substrate and inhibitor interactions. Bianchini EP, Pike RN, Le Bonniec BF. J. Biol. Chem. 279 3671-3679 (2004)
- Antisense oligodeoxynucleotides against thrombomodulin suppress the cell growth of lung adenocarcinoma cell line A549. Fujiwara M, Jin E, Ghazizadeh M, Kawanami O. Pathol. Int. 52 204-213 (2002)
- Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C. Díez N, Montes R, Alonso A, Medina P, Navarro S, España F, Hermida J. J. Thromb. Haemost. 4 398-402 (2006)
- Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator. Schenk-Braat EA, Morser J, Rijken DC. Eur. J. Biochem. 268 5562-5569 (2001)
- Salmon-derived thrombin inhibits development of chronic pain through an endothelial barrier protective mechanism dependent on APC. Smith JR, Galie PA, Slochower DR, Weisshaar CL, Janmey PA, Winkelstein BA. Biomaterials 80 96-105 (2016)
- A Machine Learning Approach for Hot-Spot Detection at Protein-Protein Interfaces. Melo R, Fieldhouse R, Melo A, Correia JD, Cordeiro MN, Gümüş ZH, Costa J, Bonvin AM, Moreira IS. Int J Mol Sci 17 (2016)
- A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor. Plug T, Kramer G, Meijers JC. J. Thromb. Haemost. 12 1717-1725 (2014)
- Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va. Gale AJ, Griffin JH. Proteins 54 433-441 (2004)
- Hydrogen/Deuterium Exchange and Nuclear Magnetic Resonance Spectroscopy Reveal Dynamic Allostery on Multiple Time Scales in the Serine Protease Thrombin. Peacock RB, Komives EA. Biochemistry 60 3441-3448 (2021)
- Mutations in the fourth EGF-like domain affect thrombomodulin-induced changes in the active site of thrombin. Koeppe JR, Beach MA, Baerga-Ortiz A, Kerns SJ, Komives EA. Biochemistry 47 10933-10939 (2008)
- Role of the N-terminal epidermal growth factor-like domain of factor X/Xa. Kittur FS, Manithody C, Rezaie AR. J. Biol. Chem. 279 24189-24196 (2004)
- The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin. Chahal G, Thorpe M, Hellman L. PLoS ONE 10 e0129511 (2015)
- Thrombin allosteric modulation revisited: a molecular dynamics study. de Amorim HL, Netz PA, Guimarães JA. J Mol Model 16 725-735 (2010)
- Functional analysis of mutant variants of thrombin-activatable fibrinolysis inhibitor resistant to activation by thrombin or plasmin. Miah MF, Boffa MB. J. Thromb. Haemost. 7 665-672 (2009)
- Mutagenesis studies toward understanding allostery in thrombin. Qureshi SH, Yang L, Manithody C, Iakhiaev AV, Rezaie AR. Biochemistry 48 8261-8270 (2009)
- Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation. Shirai Y, Uwagawa T, Shiba H, Shimada Y, Horiuchi T, Saito N, Furukawa K, Ohashi T, Yanaga K. Surgery 161 1675-1682 (2017)
- Uncovering Large-Scale Conformational Change in Molecular Dynamics without Prior Knowledge. Melvin RL, Godwin RC, Xiao J, Thompson WG, Berenhaut KS, Salsbury FR. J Chem Theory Comput 12 6130-6146 (2016)
- A steady-state competition model describes the modulating effects of thrombomodulin on thrombin inhibition by plasminogen activator inhibitor-1 in the absence and presence of vitronectin. Dekker RJ, Pannekoek H, Horrevoets AJ. Eur. J. Biochem. 270 1942-1951 (2003)
- Allosteric inhibition of the neuropeptidase neurolysin. Hines CS, Ray K, Schmidt JJ, Xiong F, Feenstra RW, Pras-Raves M, de Moes JP, Lange JH, Melikishvili M, Fried MG, Mortenson P, Charlton M, Patel Y, Courtney SM, Kruse CG, Rodgers DW. J. Biol. Chem. 289 35605-35619 (2014)
- Missense mutations in the gene encoding prothrombin corresponding to Arg596 cause antithrombin resistance and thrombomodulin resistance. Takagi Y, Murata M, Kozuka T, Nakata Y, Hasebe R, Tamura S, Takagi A, Matsushita T, Saito H, Kojima T. Thromb. Haemost. 116 1022-1031 (2016)
- Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat. Tsuruta K, Kodama T, Serada M, Hori K, Inaba A, Miyake T, Kohira T. Xenobiotica 39 125-134 (2009)
- A critical role for Gly25 in the B chain of human thrombin. Akhavan S, Miteva MA, Villoutreix BO, Venisse L, Peyvandi F, Mannucci PM, Guillin MC, Bezeaud A. J. Thromb. Haemost. 3 139-145 (2005)
- Modulation of procarboxypeptidase R (ProCPR) activation by complementary peptides to thrombomodulin. Shimomura Y, Kawamura T, Komura H, Campbell W, Okada N, Okada H. Microbiol. Immunol. 47 241-245 (2003)
- Screening the molecular surface of human anticoagulant protein C: a search for interaction sites. Villoutreix BO, Covell DG, Blom AM, Wallqvist A, Friedrich U, Dahlbäck B. J. Comput. Aided Mol. Des. 15 13-27 (2001)
- Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine. Salvagnini C, Gharbi S, Boxus T, Marchand-Brynaert J. Eur J Med Chem 42 37-53 (2007)
- Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex. Heurich M, Preston RJ, O'Donnell VB, Morgan BP, Collins PW. Thromb. Res. 145 84-92 (2016)
- Why Ser and not Thr brokers catalysis in the trypsin fold. Pelc LA, Chen Z, Gohara DW, Vogt AD, Pozzi N, Di Cera E. Biochemistry 54 1457-1464 (2015)
- Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin. Fortenberry YM, Whinna HC, Cooper ST, Myles T, Leung LL, Church FC. J. Thromb. Haemost. 5 1486-1492 (2007)
- Mutagenesis studies toward understanding the mechanism of the cofactor function of thrombomodulin. Rezaie AR, Yang L. Biophys. Chem. 117 255-261 (2005)
- Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction. Corral-Rodríguez MÁ, Bock PE, Hernández-Carvajal E, Gutiérrez-Gallego R, Fuentes-Prior P. Blood 117 7164-7173 (2011)
- Comment Enzymology. Not just an active site. Banner DW. Nature 404 449-450 (2000)
- Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots. Tanka-Salamon A, Komorowicz E, Szabó L, Tenekedjiev K, Kolev K. PLoS ONE 11 e0167806 (2016)
- Comment Mechanism of thrombin's enigmatic sodium switch revealed. Abrahams JP, Thomassen EA. Structure 11 363-364 (2003)
- Structural investigations of recombinant urokinase growth factor-like domain. Beloglazova IB, Beabealashvilli RSh, Gursky YG, Bocharov EV, Mineev KS, Parfenova EV, Tkachuk VA. Biochemistry Mosc. 78 517-530 (2013)
- The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice. Kawasoe J, Uchida Y, Miyauchi T, Kadono K, Hirao H, Saga K, Watanabe T, Ueda S, Terajima H, Uemoto S. Am J Transplant 21 540-551 (2021)
- The plasma concentration of activated protein C appears normal in patients with haemophilia. Schulman S, Eelde A, Blombäck M, Stenflo J. Haemophilia 15 566-570 (2009)
- Thrombin's faces revealed: cellular effects include induction of neoangiogenesis. Bahou WF. J. Thromb. Haemost. 1 2078-2080 (2003)
- Cryo-EM structure of the prothrombin-prothrombinase complex. Ruben EA, Summers B, Rau MJ, Fitzpatrick JAJ, Di Cera E. Blood 139 3463-3473 (2022)
- Dynamic Consequences of Mutation of Tryptophan 215 in Thrombin. Peacock RB, Davis JR, Markwick PRL, Komives EA. Biochemistry 57 2694-2703 (2018)
- Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura. Lu R, Sui J, Zheng XL. Blood Adv 4 5378-5388 (2020)
- Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency. Thomson JJ, Retter A, Hunt BJ. Blood Coagul. Fibrinolysis 21 598-600 (2010)
- Role of the activation peptide in the mechanism of protein C activation. Stojanovski BM, Pelc LA, Di Cera E. Sci Rep 10 11079 (2020)
- Slow thrombin in solution. Huntington JA. Biochem. J. 390 e1-3 (2005)
- A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder. Osada M, Maruyama K, Kokame K, Denda R, Yamazaki K, Kunieda H, Hirao M, Madoiwa S, Okumura N, Murata M, Ikeda Y, Watanabe K, Tsukada Y, Kikuchi T. Blood Adv 5 3830-3838 (2021)
- Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor. Lee W, Lee S, Choi J, Park JH, Kim KM, Jee JG, Bae JS. Sci Rep 7 14862 (2017)
- Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern. Pfeffer I, Brewitz L, Krojer T, Jensen SA, Kochan GT, Kershaw NJ, Hewitson KS, McNeill LA, Kramer H, Münzel M, Hopkinson RJ, Oppermann U, Handford PA, McDonough MA, Schofield CJ. Nat Commun 10 4910 (2019)
- Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation. Brewitz L, Onisko BC, Schofield CJ. J Biol Chem 298 102129 (2022)
- Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I. Billur R, Ban D, Sabo TM, Maurer MC. Biochemistry 56 6343-6354 (2017)
- End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity. Liu X, Boron M, Zhao Y, Sun XL. Eur J Pharm Sci 139 105066 (2019)
- Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction. Turan A, Zhang L, Tarique M, Ulker V, Arguc FN, Badal D, Yolcu ES, Shirwan H. Am J Transplant 23 619-628 (2023)
- LC3B Binds to the Autophagy Protease ATG4b with High Affinity Using a Bipartite Interface. Tang Y, Kay A, Jiang Z, Arkin MR. Biochemistry 61 2295-2302 (2022)
- Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential. Wu C, Stafford AR, Fredenburgh JC, Weitz JI, Gils A, Declerck PJ, Kim PY. Thromb. Haemost. 117 1509-1517 (2017)
- New insight into the traditional model of the coagulation cascade and its regulation: illustrated review of a three-dimensional view. Troisi R, Balasco N, Autiero I, Sica F, Vitagliano L. Res Pract Thromb Haemost 7 102160 (2023)
- Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer. Takaki W, Konishi H, Matsubara D, Shoda K, Arita T, Kataoka S, Shibamoto J, Furuke H, Takabatake K, Shimizu H, Komatsu S, Shiozaki A, Kubota T, Okamoto K, Otsuji E. Int J Mol Sci 23 3264 (2022)
- Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I. Billur R, Sabo TM, Maurer MC. Biochemistry 58 1048-1060 (2019)
- Visualizing correlated motion with HDBSCAN clustering. Melvin RL, Xiao J, Godwin RC, Berenhaut KS, Salsbury FR. Protein Sci. 27 62-75 (2018)
- Zymogen and activated protein C have similar structural architecture. Stojanovski BM, Pelc LA, Zuo X, Di Cera E. J Biol Chem 295 15236-15244 (2020)